FDA Inspection
PPD Development, L.P.PPD Development, L.P. – FDA Inspection, Sep 25, 2025
Record Details
This FDA Inspection record concerns PPD Development, L.P., with an inspection on September 25, 2025, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · b5b40b46-bc35-4341-ab56-8360b5d286c7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1284012
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of PPD Development, L.P.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 1, 2026 | Not classified | Minneapolis District Office | |
| April 5, 2023 | NAI | Minneapolis District Office | |
| July 16, 2021 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 19, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for PPD Development, L.P.
- FDA Inspection 1320960 - 2026-05-01
- FDA Inspection 1202015 - 2023-04-05
- FDA Inspection 1146503 - 2021-07-16
- FDA Inspection 1105196 - 2019-09-19
- FDA Inspection 1056412 - 2018-05-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.